Renovia, Inc.
6
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
16.7%
1 terminated/withdrawn out of 6 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
25%
1 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Intravaginal Devices for Pelvic Floor Motion
Role: collaborator
Pelvic Floor Muscle Training With a Digital Therapeutic Device to Standard Exercises for Stress Urinary Incontinence
Role: lead
Use of the Leva Pelvic Digital Health System in Women With Fecal Incontinence
Role: lead
Comparing Use of a Digital Health System of Pelvic Floor Exercise Program to Kegel Exercises in Stress Urinary Incontinence
Role: lead
Pelvic Floor Muscle Training With Leva System for Urge Incontinence
Role: collaborator
Use of the Leva Incontinence System in Treating Bladder Incontinence.
Role: lead
All 6 trials loaded